Paliperidone Tablet, Extended Release
Product Images NDC 27808-224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 27808-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tris Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Paliperidone Extended Release Tablets 1)

Chemical Structure (Paliperidone Extended Release Tablets 1)
Chemical structure diagram of paliperidone, the active ingredient in the extended release tablet formulation shown in the product data. The diagram displays the molecular framework with labeled rings and bonds typical for this antipsychotic compound.*
FDA Label Image

1.5mgbottlelabel30 (Paliperidone Extended Release Tablets 2)

1.5mgbottlelabel30 (Paliperidone Extended Release Tablets 2)
Paliperidone Extended-Release Tablets 1.5 mg oral tablets packaging label. The label states the tablets should be swallowed whole and are for prescription use only. The package contains 30 tablets. The labeler is Tris Pharma Inc., with manufacturing by CSPC Ouyi Pharmaceutical Co., Ltd. in China. Storage and usage instructions are provided along with the NDC number 27808-222-01.*
FDA Label Image

3mgbottlelabel30s (Paliperidone Extended Release Tablets 3)

3mgbottlelabel30s (Paliperidone Extended Release Tablets 3)
Paliperidone Extended-Release Tablets 3 mg label for oral use, manufactured by Tris Pharma Inc. The label states the tablets should be swallowed whole, not divided, crushed, or chewed. It includes storage instructions, manufacturer details, and a quantity of 30 tablets with Rx only designation. A barcode and QR code box with GTIN, SN, EXP, and LOT information are visible.*
FDA Label Image

6mgbottlelabel (Paliperidone Extended Release Tablets 4)

6mgbottlelabel (Paliperidone Extended Release Tablets 4)
Paliperidone Extended-Release Tablets 6 mg, oral dosage form, in a package containing 30 tablets. The label instructs that tablets should be swallowed whole and not divided, crushed, or chewed. Manufactured for Tris Pharma Inc., with storage and handling details provided. The label also includes a barcode and a QR code with GTIN, SN, EXP, and LOT placeholders.*
FDA Label Image

9mgbottlelabel30s (Paliperidone Extended Release Tablets 5)

9mgbottlelabel30s (Paliperidone Extended Release Tablets 5)
Label for Paliperidone Extended-Release Tablets 9 mg, oral tablet strength, by Tris Pharma Inc. The label includes dosage instructions, storage conditions, manufacturer details, a barcode, and a QR code. The package contains 30 tablets, Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.